Quest Diagnostics Inc Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
5-Yr Fwd EPS Growth
10.0%projected annual EPS growth
Analyst Coverage
15analysts covering
FY Revenue (est.)
$12Bnext fiscal year
FY EPS (est.)
$11.19next fiscal year
Reporting Calendar
| Event | Expected Date |
|---|---|
| Q3 2026 Earnings Release | 22 Oct 2026 |
Monitoring Framework
Key Performance Indicators
Organic Requisition Volume Growth Quarterly1,090.0%
Invigorate Program Annual Cost Savings Annually3.0Target: 3.0%
Advanced Diagnostics Revenue Growth QuarterlyTarget: Double-digit growth
Watch Items
- Project Nova IT Modernization DilutionTrigger: Dilution exceeding $0.25 per share in FY 2026Action: Monitor quarterly requisition volume and revenue per requisition trends for negative mix shifts.
- PAMA (Protecting Access to Medicare Act) Rate CutsTrigger: Operating margin compression >50 bps YoY sustained over 2 consecutive quarters or organic requisition volume growth dropping below 2.0%.Action: Accelerate Invigorate cost-saving initiatives and shift test mix toward high-margin advanced diagnostics.
Research as of 2 Sep 2026